Please assess the completion status of the following clinical trial:

Trial Title: Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy, ambulatory, male and female subjects ≥ 18 years of age~* Presence of sore throat due to upper respiratory tract infection (URTI)~* Onset of sore throat pain within six days of the screening period~* Baseline sore throat pain intensity score ≥ 60 mm on the Sore Throat Pain Intensity Scale~* Have a score ≥ 5 on the Tonsillopharyngitis Assessment~* Female subjects of childbearing potential who are currently sexually active must be using a medically acceptable form of birth control for at least one month prior to screening (three months on oral contraceptives), e.g., oral or patch contraceptives, intrauterine device, Nuvaring, Depo-Provera, or double-barrier and have a negative pregnancy test at screening/treatment period. Female subjects of non-childbearing potential must be amenorrheic for at least two years or had a hysterectomy and/or bilateral oophorectomy.~* Understand the pain rating assessments~Exclusion Criteria:~* History of hypersensitivity to aspirin, salicylates, other nonsteroidal anti-inflammatory drugs, acetaminophen, opioid analgesics, and similar drugs~* Use of any cold medication (i.e. decongestants, antihistamines, expectorants, antitussives) within four hours preceding administration of the investigational product~* Use of any immediate release analgesic/antipyretic within four hours or use of any sustained release or long-acting analgesic/antipyretic within twelve hours preceding administration of the investigational product~* Consumption of alcoholic beverages, or foods and beverages containing xanthines within two hours prior to administration of the investigational product~* Use of any sore throat lozenges, sprays, cough drops, menthol-containing products within one hour preceding administration of the investigational product~* Presence of cough that causes throat discomfort~* Presence of mouth-breathing or any respiratory condition that, in the Investigator's judgment, could compromise breathing~* Evidence of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic diseases, or malignancies for which aspirin or acetaminophen is contraindicated~* Relevant concomitant disease such as medically uncontrolled asthma (exercise induced asthma is permitted), chronic sinusitis or nasal structural abnormalities causing greater than fifty percent obstruction~* History of gastrointestinal bleeding or perforation related to previous non-steroidal anti-inflammatory therapy.~* Current or past history of a bleeding disorder~* Self reported alcoholism or drug abuse within two years prior to screening or routine consumption of three or more alcohol containing beverages per day~* Habituation to analgesic drugs or tranquilizers (i.e., routine use of five or more times per week for greater than three weeks)~* Acute illness, local infection, or disease (other than URTI with pharyngeal infection) that can interfere with the conduct of the study~* Current use of blood thinning (anticoagulant), low dose aspirin, or steroid drug~* Has initiated treatment for depression within the past thirty days~* Females who are pregnant or lactating

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): None
- Arm 2 (Type: ACTIVE_COMPARATOR): None
- Arm 3 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete